Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma.
暂无分享，去创建一个
M. Czuczman | D. Maloney | J. Rosenberg | P. Mclaughlin | C. White | N. Berinstein | I. Bence-Bruckler | D. Shen | D. Green | J. Rosenberg | A. Grillo‐López | A. Grillo-López | P. Mclaughlin | I. Bence‐Bruckler | D. Green